Increasing patient awareness and rising demand for high quality care have made it imperative for healthcare providers to develop targeted therapies through specific and sensitive diagnostic tests. Clinical diagnostic tests are used to diagnose a medical condition, provide information about the patient’s health, or monitor a course of disease and assess the patient’s response to treatments. Various techniques... View more

Increasing patient awareness and rising demand for high quality care have made it imperative for healthcare providers to develop targeted therapies through specific and sensitive diagnostic tests. Clinical diagnostic tests are used to diagnose a medical condition, provide information about the patient’s health, or monitor a course of disease and assess the patient’s response to treatments. Various techniques of clinical diagnostic testing include blood gas testing, clinical chemistry, immunoassay, coagulation testing, hematology, polymerase chain reaction (PCR), and staining method.

Typically, clinical diagnostic tests involve use of antibody-based techniques for recognizing proteins or disease markers. However, these immunoassays cannot identify all biomarkers in one test and are prone to false-positive and false-negative results. Therefore, there is growing demand for more accurate, efficient, and reliable technologies. This has led to development of alternative testing methods such as LC-MS and GC-MS. However, high initial capital investment and lack of skilled labor is deterring adoption of advance testing devices. Major instruments used in clinical diagnostics include immunoassay analyzer, HPLC system, chemical analyzer, mass spectrometer (MS), LC-MS, and GC-MS. The use of reagents has simplified the testing practice and workflow for personnel in diagnostic laboratories.

New Techniques in Use

Molecular diagnostics is driving growth of the personalized medicine market which involves co-development of drugs/devices and specialized diagnostic tests. The technique is also referred to as companion diagnostic and can be used for toxicity studies, dose selection, monitoring patient response, and patient stratification.

Rapid diagnostic tests are performed at the physician office laboratory (POL), hospitals, health centers and home care. Demand for these tests is increasing rapidly owing to faster and accurate results. Tests have been developed for HbA1c testing, drug abuse, pregnancy testing, micro albumin, creatinine, blood gases, RSV, etc.

Demand for In-vitro diagnostics (IVD) is increasing in emerging markets such as India, China, Brazil, and South Korea. In-vitro diagnostic techniques have transformed the diagnostics industry by eliminating the complex in-vivo testing methods. The IVD techniques include the advance PCR technique, assays and hematology testing, helps diagnose and monitor patient’s health condition using samples of blood, cells or tissues.

Immunoassay diagnostics is expected to be driven by technological advancements such as novel biomarkers, ultrasensitive detection system and assays.

Fragmented Market

The diagnostic landscape, especially in the emerging countries, is highly fragmented and marked by the strong presence of unorganized diagnostic labs. Global players are now building global networks by investing in foreign markets. Moreover, in terms of manufacturers, the market is fragmented in a similar manner with many small players dominating local markets. Owing to the increasing demand for home care, manufacturers and diagnostic laboratories need to work in collaboration to provide quality care at patient convenience.

Conclusion

Increasing healthcare costs is deterring patients from undergoing regular health tests that can be improved with a wider insurance coverage. Inadequate insurance coverage in emerging economies is restricting patients from undergoing expensive health tests, thus fueling the market growth. Moreover, centralization of testing laboratories is projected to drive demand for high volume instrumentation and automation equipment. Demand for IVD tests from Asia Pacific, Latin America and the Middle East markets is also increasing rapidly.View less

Clinical Diagnostic Published Insights

Coherent Market Insights Hematology Market

Published Date : Jan 2020

Hematology is a branch of science dealing with diagnosis, treatment, and study of blood, blood components, and disorders related to blood such as blood malignant growth, frailty, hemophilia, and blood clumps. Hematological tests include in vitro diagnostic tests which... View more

Coherent Market Insights Neurological Disorder Diagnostics Market

Published Date : Dec 2019

Neurological disorder diagnostic tools are used for the diagnosis of various neurological disorders such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and others. Neurological disorders can be diagnosed with the use of imaging and... View more

Coherent Market Insights Blood Stream Infection Testing Market

Published Date : Jul 2019

Blood stream infection is a condition in which the blood is detected with bacterial, fungal, or any other infection. This condition normally occurs when the infection enters the blood stream of any part of body through wound, injection or during any surgical procedure... View more

Coherent Market Insights Automated Antimicrobial Susceptibility Testing Market

Published Date : May 2019

Automated antimicrobial susceptibility testing products are of two types, consumables and instruments. Consumables used in automated antimicrobial susceptibility testing includes culture & growth media, ready-to-use reagents, complete reagent kits, susceptibility ... View more

Coherent Market Insights Glycated Albumin Market

Published Date : Jul 2018

Glycated albumin refers to albumin that are bonded to glucose. Albumin is present in blood and body fluids organs, and functions to maintain the shape of cell and helps in the distribution of hormones, nutrients, and some drugs in the body. Glycated albumin has been d... View more

Coherent Market Insights Helicobacter Pylori Diagnostics Market

Published Date : Jun 2018

Helicobacter pylori is a bacteria that resides on the lining of human stomach. Helicobacter produces chemicals, causing inflammation of stomach, which progresses to peptic ulcer... View more

Coherent Market Insights Point Of Care Infectious Disease Diagnostics Market

Published Date : Apr 2018

Emerging economies such as Africa (West Africa), India, Brazil, and China have limited centralized laboratory facilities. In emerging economies point of care diagnostic is needed due to unavailability of labs, infrastructure, associated costs, and trained personnel. M... View more

LogoCredibility and Certifications

Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.